Annals of Clinical and Translational Neurology (Mar 2023)

No pain, no strain: Targin® mitigates pain and constipation following spinal cord injury

  • Rahul Sachdeva,
  • Ali Hosseinzadeh,
  • Aaron Rizzardo,
  • Andrea Maharaj,
  • Michael Berger,
  • Andrei Krassioukov

DOI
https://doi.org/10.1002/acn3.51734
Journal volume & issue
Vol. 10, no. 3
pp. 453 – 458

Abstract

Read online

Abstract Background Opioids effectively reduce chronic pain, but present significant side effects including opioid‐induced constipation. Oxycodone/naloxone decreases pain and constipation in cancer patients, however its effect on spinal cord injury population remains understudied. Methods We assessed whether oxycodone/naloxone reduces pain, constipation, and severity of autonomic dysreflexia in an individual with spinal cord injury. A 55‐year‐old male with C5 lesion presented with chief complaint of chronic pain received 5/2.5 mg and 20/10 mg oxycodone/naloxone for 6 and 2 weeks, respectively. Results Oxycodone/naloxone improved pain, bowel function, and autonomic dysreflexia severity. Interpretation Oxycodone/naloxone was effective in managing chronic pain and constipation in the studied case.